| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_790f02205c74672d4fbb7785f27d682a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-12095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-12068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-3966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00867 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 |
| filingDate |
2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf72ba3769b92872cb807dc196faa55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b90f324236ebaf4c38ba8ba1958fe98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5788df810a096a7cd2b45bf3a38595 |
| publicationDate |
2021-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021106337-A1 |
| titleOfInvention |
Filamentary devices for treatment of vascular defects |
| abstract |
Devices and methods for treatment of a patient's vasculature are described. Embodiments may include a resilient self-expanding permeable implant having a radially constrained elongated state configured for delivery within a catheter lumen and an expanded state with a longitudinally shortened configuration, and a plurality of elongate filaments which are woven together. Each of the plurality of elongate filaments may have a diameter between about 0.0005 and about 0.005 inches. The implant includes at least some filaments consisting of nitinol and at least some composite filaments that are drawn filled tube wires comprising an external nitinol tube and a highly radiopaque material concentrically disposed within the external tube. The implant has at least about 40% composite filaments relative to a total number of filaments, and wherein a total number of filaments is about 10 to about 300. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11284901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357511-B2 |
| priorityDate |
2013-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |